200 related articles for article (PubMed ID: 23108602)
41. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.
Palčevski G; Skočibušić N; Vlahović-Palčevski V
Eur J Clin Pharmacol; 2012 Jul; 68(7):1073-7. PubMed ID: 22307225
[TBL] [Abstract][Full Text] [Related]
42. Drug Utilization in Neonatal Intensive Care Unit of a Tertiary-care Hospital in Mumbai, India.
Chauthankar SA; Marathe PA; Potey AV; Nanavati RN
Indian Pediatr; 2017 Nov; 54(11):931-934. PubMed ID: 28849769
[TBL] [Abstract][Full Text] [Related]
43. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
44. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units.
Lass J; Käär R; Jõgi K; Varendi H; Metsvaht T; Lutsar I
Eur J Clin Pharmacol; 2011 Dec; 67(12):1263-71. PubMed ID: 21667125
[TBL] [Abstract][Full Text] [Related]
45. Unlicensed and off-label drug use in a neonatal unit in France.
Nguyen KA; Claris O; Kassai B
Acta Paediatr; 2011 Apr; 100(4):615-7. PubMed ID: 21410525
[No Abstract] [Full Text] [Related]
46. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
47. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.
Kumar P; Walker JK; Hurt KM; Bennett KM; Grosshans N; Fotis MA
J Pediatr; 2008 Mar; 152(3):412-5. PubMed ID: 18280851
[TBL] [Abstract][Full Text] [Related]
48. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
Dos Santos L; Heineck I
Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
[TBL] [Abstract][Full Text] [Related]
49. Large differences in neonatal drug use between NICUs are common practice: time for consensus?
Flint RB; van Beek F; Andriessen P; Zimmermann LJ; Liem KD; Reiss IKM; de Groot R; Tibboel D; Burger DM; Simons SHP;
Br J Clin Pharmacol; 2018 Jun; 84(6):1313-1323. PubMed ID: 29624207
[TBL] [Abstract][Full Text] [Related]
50. [High prevalence of off-label and unlicensed drug prescribing in a Brazilian intensive care unit].
Ferreira Lde A; Ibiapina Cda C; Machado MG; Fagundes ED
Rev Assoc Med Bras (1992); 2012; 58(1):82-7. PubMed ID: 22392321
[TBL] [Abstract][Full Text] [Related]
51. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
Tukayo BLA; Sunderland B; Parsons R; Czarniak P
PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
[TBL] [Abstract][Full Text] [Related]
52. Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing.
Aamir M; Khan JA; Shakeel F; Shareef R; Shah N
BMC Pediatr; 2018 Jul; 18(1):242. PubMed ID: 30045715
[TBL] [Abstract][Full Text] [Related]
53. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study.
Barr J; Brenner-Zada G; Heiman E; Pareth G; Bulkowstein M; Greenberg R; Berkovitch M
Am J Perinatol; 2002 Feb; 19(2):67-72. PubMed ID: 11938479
[TBL] [Abstract][Full Text] [Related]
54. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
55. Unlicensed and off-label drug use in children: implications for safety.
Choonara I; Conroy S
Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
[TBL] [Abstract][Full Text] [Related]
56. The conundrum of off-label and unlicensed drug usage in neonatology.
Jain L
J Pediatr (Rio J); 2012; 88(6):449-51. PubMed ID: 23269115
[No Abstract] [Full Text] [Related]
57. Predictive power of serial neonatal therapeutic intervention scoring system scores for short-term mortality in very-low-birth-weight infants.
Wu PL; Lee WT; Lee PL; Chen HL
Pediatr Neonatol; 2015 Apr; 56(2):108-13. PubMed ID: 25246194
[TBL] [Abstract][Full Text] [Related]
58. Off-label paediatric drug use in an Indonesian community setting.
Abdulah R; Khairinisa MA; Pratiwi AA; Barliana MI; Pradipta IS; Halimah E; Diantini A; Lestari K
J Clin Pharm Ther; 2015 Aug; 40(4):409-12. PubMed ID: 25884353
[TBL] [Abstract][Full Text] [Related]
59. The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals.
Marchetti F; Bua J; Ventura A; Notarangelo LD; Di Maio S; Migliore G; Bonati M
Eur J Clin Pharmacol; 2007 Jan; 63(1):81-5. PubMed ID: 17124577
[TBL] [Abstract][Full Text] [Related]
60. Use of technology as an evaluation tool of clinical care in preterm newborns.
Mendes I; Carvalho Md; Almeida RT; Moreira ME
J Pediatr (Rio J); 2006; 82(5):371-6. PubMed ID: 17003941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
